Search Form

Filters
clear all
Filters
Topics
Markets
Type
Brand
Workers' Comp Article

Ask The Pharmacist: Understanding the Different Types of Drug Recalls

May 1, 2024
3 MIN READ

Drugs can be withdrawn from the market for a number of reasons, ranging from minor labeling errors to the potential risk of severe health consequences. The process  behind these recalls are diverse but essential for safeguarding public health.

Workers' Comp White Paper

Strategies for Combating Mental Health Challenges in Injured Employees

April 23, 2024
1 MIN READ

A Guide for Carriers and Employers Are your employees struggling with mental health challenges?
Workers' Comp Article

Ask The Pharmacist: Topical vs. Systemic Pain Medication

April 1, 2024
3 MIN READ

Managing chronic pain with medications can be difficult for various reasons. Pain experiences and treatment effectiveness may differ among individuals and caregivers.

Auto Casualty Article

Enlyte Quarterly Medical Price Index

March 19, 2024
3 MIN READ

As reported by the Bureau of Labor and Statistics (BLS) in February 2024, the consumer price index in the United States increased 3.1% over the preceding 12 months. The medical care index rose 0.5% in January 2024. The index for hospital services increased 1.6% over the month and the index for physician’s services increased 0.6% which would be compared to Enlyte’s data in this report.

Workers' Comp Article

Ask The Pharmacist: The Role of a Pharmacy and Therapeutics (P&T) Committee

March 1, 2024
2 MIN READ

A Pharmacy and Therapeutics (P&T) committee plays a crucial role in the realm of health care, particularly in the context of a workers’ compensation pharmacy benefit manager (PBM). This committee is comprised of health care professionals, such as physicians and pharmacists, who are responsible for evaluating and making decisions about the formulary—a continually updated list of medications covered by a prescription drug plan.
Workers' Comp Podcast

Closing Loopholes: Tackling Drug Price Inflation in Work Comp

February 22, 2024

Enlyte Article

Enlytened Trends Report 2024 Annual Edition

February 7, 2024
22 MIN READ

Be the first to know how emerging trends in generative AI, auto and casualty claims and regulatory compliance are impacting P&C this year and beyond.
Workers' Comp Article

Ask The Pharmacist: Risk Assessment for Opioid Use Disorder (OUD)

February 6, 2024
3 MIN READ

On December 19, 2023, the U.S. Food and Drug Administration (FDA) approved the first test (AvertD) that uses DNA in assessing whether certain individuals may have an elevated risk of developing opioid use disorder (OUD).